Learn More
Invitrogen™ Rabbit anti-Human IgD Recombinant Secondary Antibody
Description
This antibody reacts to human IgD. No cross reactivity with human IgG, IgM, IgA, or IgE. Recombinant rabbit monoclonal antibodies are produced using in vitro expression systems. The expression systems are developed by cloning in the specific antibody DNA sequences from immunoreactive rabbits. Then, individual clones are screened to select the best candidates for production. The advantages of using recombinant rabbit monoclonal antibodies include: better specificity and sensitivity, lot-to-lot consistency, animal origin-free formulations, and broader immunoreactivity to diverse targets due to larger rabbit immune repertoire.
Specifications
Specifications
| Antigen | Human IgD |
| Applications | ELISA |
| Classification | Recombinant Monoclonal |
| Clone | RM123 |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH 7.2-7.4 |
| Host Species | Rabbit |
| Immunogen | Peptide corresponding to Human IgD. |
| Purification Method | Protein A |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.